Assessing the Risk of Birth Defects Associated with Exposure to Fixed-Dose Combined Antituberculous Agents during Pregnancy in Rats
Figure 1
(a) The micrograph of the liver section obtained from first filial control rats, magnification ×400. (A) Hepatic central vein, (B) normal hepatocyte. (b) The micrograph of the liver section obtained from first filial rats treated with fixed-dose combined antituberculous agents, magnification ×400. (A) Hepatic necrosis, (B) hepatic central vein. (c) The micrograph of the liver section obtained from first filial rats treated with fixed-dose combined antituberculous agents plus vitamin C, mag ×40. (A) Hepatocytes with intracytoplasmic inclusions, (B) hepatic central veins.
